Immunome Inc (IMNM) Price Prediction & ForecastIMNMImmunome Inc

Alphio's IMNM stock price prediction model matches the current Immunome Inc tape against historical breakout patterns, then publishes 1-day and 1-week targets first. The 1-day print is $27.13 (-1.59%). The 1-week path is $28.40 (+3.00%). Longer windows use the same pattern set plus seasonality; the 1-month and multi-year forecasts sit behind unlock because they include precise min / avg / max bands.

Immunome Inc is a good buy right now due to its promising clinical data and strong cash position. The current price is $27.57, and analysts have set a price target of up to $37, indicating potential upside of 34%. Additionally, the company has a cash reserve of $582.7 million, which is expected to fund operations into 2028, mitigating short-term financial risks. However, the main risk is the negative net income, which stands at -$73.1 million for Q2 2026, indicating ongoing losses that investors should monitor closely.

Immunome Inc (IMNM) last closed at $27.57, losing -4.50%. These facts feed the 1-day and 1-week IMNM price prediction above.